Ladenburg Thalmann Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $30
Buy Rating for Achieve Life Sciences on Cytisinicline's Promise in Nicotine Addiction Treatment
Express News | Achieve Life Sciences Announces FDA Granted Breakthrough Therapy Designation For Cytisinicline
Express News | Achieve Life Sciences Inc - Plans End-of-Phase 2 Meeting With FDA
Express News | Achieve Life Sciences Announces FDA Grants Breakthrough Therapy Designation to Cytisinicline for the Treatment of E-Cigarette or Vaping Nicotine Dependence
Achieve Life Sciences Shares Fall After Securing $20 Million Debt Refinancing Deal
Lake Street Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $11
Achieve Life Sciences (ACHV) Gets a Buy From Lake Street
Express News | Achieve Life Sciences: New Agreement Extends Maturity Date to December 1, 2027
Express News | Achieve Life Sciences Announces $20M Loan Refinancing With Silicon Valley Bank
Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 13, 2024
JonesTrading Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $20
JonesTrading Keeps Their Buy Rating on Achieve Life Sciences (ACHV)
Achieve Life Sciences to Present at JonesHealthcare Seaside Summit 2024
With 64% Ownership of the Shares, Achieve Life Sciences, Inc. (NASDAQ:ACHV) Is Heavily Dominated by Institutional Owners
Express News | Achieve Life Sciences Joins U.S. Russell 3000 And Russell Microcap Indexes
Achieve Life Sciences Announces Addition to the U.S. Russell 3000 and Russell Microcap Indexes
Express News | Achieve Life Sciences Inc Files for Mixed Shelf of up to $200 Mln - SEC Filing
Express News | Achieve Life Sciences-in June, Co Entered Into Non-Binding Term Sheet to Refinance Extend Maturity Date of Term Loans With Silicon Valley Bank, Affiliates
Achieve Life Sciences (ACHV) Receives a Buy From Lake Street